IL87025A - Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences - Google Patents

Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences

Info

Publication number
IL87025A
IL87025A IL87025A IL8702588A IL87025A IL 87025 A IL87025 A IL 87025A IL 87025 A IL87025 A IL 87025A IL 8702588 A IL8702588 A IL 8702588A IL 87025 A IL87025 A IL 87025A
Authority
IL
Israel
Prior art keywords
dna sequences
production
growth factor
host cells
fibroblast growth
Prior art date
Application number
IL87025A
Other languages
English (en)
Other versions
IL87025A0 (en
Original Assignee
California Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Biotechnology Inc filed Critical California Biotechnology Inc
Publication of IL87025A0 publication Critical patent/IL87025A0/xx
Publication of IL87025A publication Critical patent/IL87025A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL87025A 1987-07-07 1988-07-07 Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences IL87025A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7079787A 1987-07-07 1987-07-07

Publications (2)

Publication Number Publication Date
IL87025A0 IL87025A0 (en) 1988-12-30
IL87025A true IL87025A (en) 1993-05-13

Family

ID=22097443

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87025A IL87025A (en) 1987-07-07 1988-07-07 Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences

Country Status (7)

Country Link
EP (2) EP0298723A1 (da)
JP (4) JP2879148B2 (da)
AU (1) AU629176B2 (da)
CA (1) CA1341639C (da)
DK (1) DK2490A (da)
IL (1) IL87025A (da)
WO (1) WO1989000198A1 (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852177A (en) * 1987-02-24 1998-12-22 Takeda Chemical Industries, Ltd. Basic fibroblast growth factor (bFGF) muteins
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
US5223483A (en) * 1987-10-22 1993-06-29 Merck & Co., Inc. Cysteine-modified acidic fibroblast growth factor
US5312911A (en) * 1987-10-22 1994-05-17 Merck & Co., Inc. Cysteine-modified acidic fibroblast growth factor
IL89661A (en) * 1988-03-17 1999-05-09 Novo Nordisk As Heparin binding proteins
US5814602A (en) * 1988-03-17 1998-09-29 Novo Nordisk A/S Heparin-binding proteins
GB2223495B (en) * 1988-08-08 1992-05-20 British Bio Technology Synthetic gene encoding basic fibroblast growth factor
GB2223497B (en) * 1988-08-08 1992-04-01 British Bio Technology Synthetic gene encoding human beta endothelial cell growth factor
GB2223496B (en) * 1988-08-08 1992-05-27 British Bio Technology Synthetic gene encoding mature human acid fibroblast growth factor
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
GB8821795D0 (en) * 1988-09-16 1988-10-19 Erba Carlo Spa New derivatives of human/bovine basic fibroplast growth factor
FR2642086B1 (fr) * 1989-01-26 1992-09-04 Sanofi Sa Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur
US7238673B2 (en) 1989-03-31 2007-07-03 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5464943A (en) * 1989-04-26 1995-11-07 Takeda Chemical Industries, Ltd. DNA encoding glycosylated FGF and production thereof
EP0394951A1 (en) * 1989-04-26 1990-10-31 Takeda Chemical Industries, Ltd. Glycosylated bFGF and production thereof
EP0406738A3 (en) * 1989-07-03 1991-08-14 Takeda Chemical Industries, Ltd. Production of acidic fgf protein
JPH0343088A (ja) * 1989-09-29 1991-02-25 Takeda Chem Ind Ltd ａＦＧＦ蛋白質の製造法
EP0420222A1 (en) * 1989-09-29 1991-04-03 Takeda Chemical Industries, Ltd. Mutein of acidic FGF, and its production
JPH047617A (ja) * 1990-04-26 1992-01-13 Canon Inc 電子機器
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
ATE164076T1 (de) * 1990-06-08 1998-04-15 Univ New York Stimulierung der stroma- und vorläuferzellen im knochenmark
DE69119869T2 (de) * 1990-11-23 1996-12-12 American Cyanamid Co Chimeres Fibroblasten-Wachstumsfaktor
US5206354A (en) * 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
IE914393A1 (en) * 1990-12-18 1992-07-01 Amgen Inc Analogs of acidic fibroblast growth factor having enhanced¹stability and biological activity
GR1002610B (el) * 1991-01-02 1997-02-20 Johnson & Johnson Consumer Products Inc. Θεραπευτικες συνθεσεις πληγων που περιεχουν παραγοντα αναπτυξης ινοβλαστων και ασκορβικον οξυ.
EP0499242B1 (en) * 1991-02-15 1996-06-26 Takeda Chemical Industries, Ltd. Stimulation of endosteal bone formation with a cell growth factor
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
CA2123803A1 (en) * 1991-11-27 1993-06-10 Samuel E. Lynch Bone regeneration
US5461029A (en) * 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
US5814605A (en) * 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
TW275068B (da) * 1993-09-24 1996-05-01 American Cyanamid Co
WO1995024873A1 (en) * 1994-03-14 1995-09-21 Cryolife, Inc. Treated tissue for implantation and preparation methods
MX9707617A (es) * 1995-06-05 1997-12-31 Human Genome Sciences Inc Factor de crecimiento de criptina humano.
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US6214795B1 (en) * 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
WO1999055861A2 (en) * 1998-04-28 1999-11-04 Eisai Co., Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
US7252818B2 (en) 1998-07-24 2007-08-07 Cardiovascular Biotherapeutics, Inc. Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
EP1246843A1 (en) * 2000-01-05 2002-10-09 ZymoGenetics, Inc. Novel fgf homolog zfgf12
AU2631001A (en) * 2000-01-05 2001-07-16 Zymogenetics Inc. Novel fgf homolog zfgf11
JP2004517607A (ja) * 2000-08-15 2004-06-17 ファージ バイオテクノロジー コーポレイション 生物学的に活性なヒト酸性線維芽細胞成長因子の産生方法および血管新生の促進におけるその使用
US8440295B2 (en) 2005-04-22 2013-05-14 Eagle Industry Co. Ltd. Mechanical seal device, sliding element, and method of production thereof
US7816140B2 (en) 2005-06-14 2010-10-19 The United States Of America As Represented By The Department Of Veterans Affairs Composition and methods for osteogenic gene therapy
WO2013090919A1 (en) * 2011-12-16 2013-06-20 Wisconsin Alumni Research Foundation Fgf-2 having enhanced stability
CN103882028B (zh) * 2014-03-18 2016-08-31 杨霞 重组人碱性成纤维细胞生长因子蛋白的制备方法
CN114746436B (zh) 2019-11-25 2024-07-02 韩国海洋科学技术院 改善温度稳定性和蛋白酶抗性的fgf2多肽及其用途
CN117486996B (zh) * 2023-12-21 2024-03-19 朗肽生物制药股份有限公司 一种改构的重组人酸性成纤维细胞生长因子的制备及其在皮肤修复中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US4868113A (en) * 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor

Also Published As

Publication number Publication date
JPH11103875A (ja) 1999-04-20
DK2490D0 (da) 1990-01-05
CA1341639C (en) 2014-07-08
JPH11103874A (ja) 1999-04-20
IL87025A0 (en) 1988-12-30
AU2084688A (en) 1989-01-30
WO1989000198A1 (en) 1989-01-12
JP2953573B2 (ja) 1999-09-27
JP2953574B2 (ja) 1999-09-27
JPH11103876A (ja) 1999-04-20
JP2879148B2 (ja) 1999-04-05
JPH03504916A (ja) 1991-10-31
AU629176B2 (en) 1992-10-01
EP0377579A1 (en) 1990-07-18
EP0298723A1 (en) 1989-01-11
DK2490A (da) 1990-03-06

Similar Documents

Publication Publication Date Title
IL87025A (en) Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences
GB8819209D0 (en) Polypeptide & dna encoding same
SG77286G (en) Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polyeptides
PH22108A (en) Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
ZA86217B (en) Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides
IL70856A0 (en) Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides
GB2182043B (en) Precursor polypeptide dna sequence coding therefor, vectors, host organisms and processes involving same
GR3033769T3 (en) Human interferon beta2A, vectors containing genes coding for said interferon, cell lines producing same.
HUT46359A (en) Dna molecules encoding deacetoxy-cefalosporin-c-synthetase and deacetyl-cefalosporin-c-synthetase and recombinant dna vectors
IL88095A0 (en) Dna sequences,proteins and gene preparations
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
EP0303859A3 (en) Cloning of dna encoding antibacterial polypeptide precursor and expression of the precursor
EP0256553A3 (en) Gene encoding insecticidal protein and production of said protein using said gene
IL89673A0 (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
EP0303858A3 (en) Cloning of dna encoding antibacterial polypeptide precursor and expression of the precursor
GB2223496B (en) Synthetic gene encoding mature human acid fibroblast growth factor
PH24603A (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
FI901764A7 (fi) Synteettinen DNA-sekvenssi, joka koodaa ihmisen insuliinin kaltaista k asvutekijää II
GB2223495B (en) Synthetic gene encoding basic fibroblast growth factor
IE852704L (en) Novel polypeptides having growth factor activity and¹nucleic acid sequences encoding the polypeptides
EP0217327A3 (en) Dna sequence encoding variant elongation factor 2
ZA84512B (en) Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides
GB8805799D0 (en) Csf-1 human nucleotide sequence used as gene promoter
GB2223497B (en) Synthetic gene encoding human beta endothelial cell growth factor